HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

Europe Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


Europe Radiopharmaceutical Synthesizer Market Insights

  • Based on Reed Intelligence findings, the Europe Radiopharmaceutical Synthesizer Market size reached USD 675.14 Million in 2024 and is expected to grow to USD 1013.9 Million by 2033.
  • During 2026–2033, the market is forecasted to advance at a CAGR of 4.6%.
  • PET represented the largest share of the Modality market in terms of size in 2024.
  • Among the Modality segments, SPECT is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • In 2024, Europe accounted for 21.57% of the global Radiopharmaceutical Synthesizer Market size.
  • By 2033, United States is projected to lead the global market in terms of market size.
  • Russia is projected to emerge as the fastest-growing market in Europe, reaching USD 82.43 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 675.14 Million
Market Size In 2033 USD 1013.9 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.6% (2025-2033)
Segmnetation Covered
Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Nordic
  8. Benelux
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports